Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-01-28 @ 6:02 PM
Study NCT ID:
NCT01853618
Status:
COMPLETED
Last Update Posted:
2019-12-10
First Post:
2013-05-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
130120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None